Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

HNX:DP3 Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,171,746	1,253,446	1,408,246	808,400	971,800	746,480
Market Cap Growth	-6.03%	-10.99%	74.20%	-16.81%	30.18%	17.30%
Enterprise Value	773,289	929,277	1,160,824	640,122	859,776	625,475
Last Close Price	54500.00	55479.03	59751.45	31646.29	36075.15	26165.97
PE Ratio	9.08	10.34	11.24	7.43	10.31	6.55
PS Ratio	2.77	3.00	3.44	1.67	2.55	1.89
PB Ratio	2.20	2.42	3.01	1.94	2.65	2.15
P/TBV Ratio	2.28	2.51	3.14	1.97	2.70	2.19
P/FCF Ratio	5.82	13.86	9.60	9.61	37.58	13.79
P/OCF Ratio	5.78	13.64	9.20	8.15	36.94	6.10
EV/Sales Ratio	1.83	2.23	2.83	1.32	2.26	1.58
EV/EBITDA Ratio	5.01	6.21	7.69	-	-	-
EV/EBIT Ratio	5.40	6.80	8.48	5.01	7.67	4.69
EV/FCF Ratio	3.84	10.27	7.91	7.61	33.24	11.56
Debt / Equity Ratio	0.03	-	0.02	0.01	0.01	0.02
Debt / EBITDA Ratio	0.09	-	0.05	-	-	-
Debt / FCF Ratio	0.07	-	0.05	0.06	0.14	0.10
Asset Turnover	-	0.71	0.76	1.02	0.86	0.97
Inventory Turnover	-	2.94	2.10	2.17	1.90	2.17
Quick Ratio	2.98	4.29	3.25	2.60	2.31	1.97
Current Ratio	3.30	4.88	3.79	3.43	3.22	2.69
Return on Equity (ROE)	-	24.55%	28.28%	27.77%	26.46%	35.19%
Return on Assets (ROA)	-	14.50%	15.87%	16.76%	15.81%	20.51%
Return on Capital (ROIC)	-	17.17%	19.03%	20.16%	19.43%	25.17%
Return on Capital Employed (ROCE)	26.80%	26.30%	29.20%	30.60%	30.60%	38.50%
Earnings Yield	11.02%	9.67%	8.89%	13.46%	9.70%	15.28%
FCF Yield	17.18%	7.22%	10.42%	10.41%	2.66%	7.25%
Dividend Yield	5.65%	-	5.02%	-	6.65%	-
Payout Ratio	49.05%	53.22%	54.84%	45.84%	70.55%	52.76%
Buyback Yield / Dilution	-0.00%	-	5.00%	-5.27%	0.00%	2.18%
Total Shareholder Return	5.65%	-	10.02%	-5.27%	6.65%	2.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.